Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
Nearly a quarter of American adults still haven't gotten their primary vaccinations even this late in the pandemic, and experts expect at least some of them to roll up their sleeves for a more conventional option - a protein-based vaccine.
Novavax CEO Stanley Erck told The Associated Press that he expected the U.S. to expand use of the vaccine beyond unvaccinated adults fairly quickly. Sharon Bentley of Argyle, Texas, is one of the holdouts. Bentley was hesitant about the first COVID-19 vaccines but then her husband volunteered for a Novavax trial, getting two doses and later a booster.
Protein vaccines have been used for years to prevent hepatitis B, shingles and other diseases. It's a very different technology than the dominant Pfizer and Moderna COVID-19 vaccines that deliver genetic instructions for the body to produce its own copies of the spike protein. The lesser-used Johnson & Johnson option uses a harmless cold virus to deliver spike-making instructions.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US regulators OK new COVID-19 shot option from NovavaxThe U.S. is getting another COVID-19 vaccine choice
Read more »
Omicron subvariants threaten COVID-19 resurgence across USHealth officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S.
Read more »
US sees doubling in hospitalizations due to COVID-19 since April, reflecting spread of new subvariantsDr. Walensky said the U.S. has seen a doubling in the number of hospitalizations due to COVID-19 since April, reflecting the spread of the new subvariants, though deaths have remained steady around 300 per day.
Read more »
Masks urged in New York City as COVID-19 omicron subvariant BA.5 cases tick upAs COVID-19 cases tick up in New York City, the Department of Health is continuing to urge residents to wear masks in all public indoor settings and in crowded areas outdoors.
Read more »
COVID-19 symptoms can linger for many weeks, CDC study saysThe symptoms could be a headache, a runny nose, a sore throat, as well as loss of smell, taste or hair. Some could even struggle with fatigue, chills or fever.
Read more »